1. Home
  2. AMBQ vs DNA Comparison

AMBQ vs DNA Comparison

Compare AMBQ & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AMBQ

Ambiq Micro Inc.

N/A

Current Price

$28.62

Market Cap

533.3M

Sector

Technology

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.25

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBQ
DNA
Founded
2010
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.3M
562.3M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
AMBQ
DNA
Price
$28.62
$8.25
Analyst Decision
Buy
Strong Sell
Analyst Count
4
1
Target Price
$41.75
$9.00
AVG Volume (30 Days)
89.8K
1.0M
Earning Date
02-14-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$72,109,000.00
$180,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.30
$7.28
P/E Ratio
N/A
N/A
Revenue Growth
10.03
N/A
52 Week Low
$22.12
$5.00
52 Week High
$51.76
$17.58

Technical Indicators

Market Signals
Indicator
AMBQ
DNA
Relative Strength Index (RSI) N/A 39.61
Support Level N/A $8.09
Resistance Level N/A $9.12
Average True Range (ATR) 0.00 0.53
MACD 0.00 0.01
Stochastic Oscillator 0.00 6.00

Price Performance

Historical Comparison
AMBQ
DNA

About AMBQ Ambiq Micro Inc.

Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: